Pentoxifylline as an adjunct therapy in children with cerebral malaria
Background. Pentoxifylline (PTX) affects many processes that may contribute to the pathogenesis of severe malaria and it has been shown to reduce the duration of coma in children with cerebral malaria. This pilot study was performed to assess pharmacokinetics, safety and efficacy of PTX in African c...
Κύριοι συγγραφείς: | Lell, B, Köhler, C, Wamola, B, Olola, C, Kivaya, E, Kokwaro, G, Wypij, D, Mithwani, S, Taylor, T, Kremsner, P, Newton, C |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
BioMed Central
2010
|
Παρόμοια τεκμήρια
-
Pentoxifylline as an adjunct therapy in children with cerebral malaria.
ανά: Lell, B, κ.ά.
Έκδοση: (2010) -
Pentoxifylline as adjunct therapy in childen with cerebral malaria [MIM-BL-72864]
ανά: Lell, B, κ.ά.
Έκδοση: (2005) -
The role of sequential administration of sulphadoxine/pyrimethamine following quinine in the treatment of severe falciparum malaria in children.
ανά: Ogutu, B, κ.ά.
Έκδοση: (2005) -
Prognostic value of circulating pigmented cells in African children with malaria.
ανά: Kremsner, P, κ.ά.
Έκδοση: (2009) -
Cerebral malaria: optimising management.
ανά: Mturi, N, κ.ά.
Έκδοση: (2003)